Table 2 Prevalence of clinical factors defining MOH as complicated
Group A (n = 46) | Group B (n = 46) | Group C (n = 45) | Statistics | |
|---|---|---|---|---|
Psychiatric comorbidity n° (%) | 26 (56.5%) | 26 (56.5%) | 30 (66.6%) | NS* |
· Anxiety disorder | 16 (34.7%) | 17 (36.9%) | 19 (42.2%) | |
· Mood disorder | 21 (45.6%) | 21 (45.6%) | 22 (48.8%) | |
· Anxiety and mood disorder | 10 (21.7%) | 10 (21.7%) | 11 (24.4%) | |
· Eating disorder | 3 (6.5%) | 2 (4.3%) | 3 (6.6%) | |
Psychiatric comorbidity alone | 8 (17.4%) | 8 (17.4%) | 11(24.4%) | |
Psychosocial and environmental problems n° (%) | 16 (34.7%) | 10 (21.7%) | 12 (26.6%) | NS* |
Psycho-social and environmental problems alone | 6 (13%) | 4 (8.7%) | 4(8.8%) | |
Relapsers n° (%) | 6 (13%) | 9 (19.5%) | 8 (17.7%) | NS§ |
Daily use of multiple drugs n° (%) | 11 (23%) | 17 (36.9%) | 17 (37.7%) | NS§ |
Medical illnesses n° (%)** | 4 (8.7%) | 2 (4.3%) | 2 (4.4%) | NS* |